The ASCO Post (@ascopost) 's Twitter Profile
The ASCO Post

@ascopost

News and views from the world of clinical oncology and hematology

ID: 96994334

linkhttp://WWW.ASCOPOST.COM calendar_today15-12-2009 14:48:51

34,34K Tweet

61,61K Takipçi

4,4K Takip Edilen

The ASCO Post (@ascopost) 's Twitter Profile Photo
The ASCO Post
@ascopost

7 days ago

Switching to camizetrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for patients with HR-positive, HER2-negative advanced breast cancer, research shows. #ASCO25 #BreastCancer ascopost.com/news/june-2025…